Breaking News

NEW YORK, Jan. 8—German functional genomics firm Atugen has struck a deal with Danish healthcare giant Novo Nordisk to jointly validate new targets for diabetes and related diseases, Atugen said on Tuesday.

NEW YORK, Jan. 8 — MorphoSys said Tuesday that it would expand its drug target identification and validation partnership with Cambridge, Mass.-based Biogen.

NEW YORK, Jan. 8 — Bayer Diagnostic and Burrill & Company said Tuesday that they had formed a new $50 million venture capital fund for diagnostic research.

NEW YORK, Jan 7—Celera Genomics has appointed David Block as executive vice president and chief operating officer of its therapeutics division, the company said on Monday. Block starts his new job on Feb. 1.

NEW YORK, Jan. 7—Idec Pharmaceuticals and ExonHit Therapeutics said Monday that they would collaborate to develop new antigen targets for antibody therapy.


NEW YORK, Jan.7 - Gyros AB and ACE BioSciences struck a proteomics collaboration, Gyros announced Monday.

NEW YORK, Jan. 7 — San Diego-based GeneFormatics said Monday that it would collaborate with Bristol-Myers Squibb to develop nuclear magnetic resonance software for high-throughput analysis of 3-D protein structures.


SAN FRANCISCO, Jan. 3 - Exelixis and Cytokinetics will partner in building a small molecule compound library, the companies said on Thursday.


Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.